Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06693479

Could a Feedback Device Help Manage Work-related Shoulder Disorders?

Work-related shoulder pain is a common problem with significant socio-economic repercussions. The impact of these disorders on workers is considerable, particularly in terms of pain, disability and reduced quality of life. Several occupational factors may explain the onset of these disorders, such as changes in the work environment, physical demands, psychosocial factors specific to the occupational context and the age of workers. The lack of quantitative measurement tools to assess the physical demands of work over an extended period of time is sorely felt. Recently, our team developed a wearable feedback device, similar to a watch worn on the arm, which measures shoulder movements and muscle activity, transforming this real-time data into clinical indicators. These indicators provide immediate feedback to workers, enabling them to better understand the physical demands of their tasks and adapt accordingly. If this device proves effective in reducing physical demands, it could become a valuable tool for guiding workplace assessments and interventions. However, this device has not yet been tested on workers with shoulder pain. For this reason, a two-part pilot study is needed to understand user needs, assess ease of use and the feasibility of implementing the device. The first component will consist of a pilot clinical trial involving 42 workers suffering from shoulder pain, divided into two groups: one group will use the feedback device for 2 weeks, while the other group will continue to work without intervention. The second phase will analyze the experience of participants who have used the device.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Centre interdisciplinaire de recherche en réadaptation et intégration sociale (Cirris)

Québec, Quebec, G1M 2S8, Canada

Location status: Recruiting

Location contact

Jean Tittley, pht, MSc

CONTACT

[email protected]

418-529-0324

Jean Tittley, pht, MSc

SUB_INVESTIGATOR

Jean-Sébastien Roy, Ph.D.

CONTACT

[email protected]

418-529-9141 ext. 46005

Philippe Meidinger, pht, Ph.Ds

PRINCIPAL_INVESTIGATOR

About this study

The objectives of this pilot study are (a) to evaluate the feasibility of implementing the SWL in the workplace and conducting a large-scale randomized clinical trial (RCT) by assessing recruitment success, intervention adherence, acceptability of the technology, the research team's capacity to refine the SWL, and (b) to explore the SWL capacity to reduce disability, pain, work limitations, and physical work demands while increasing pain self-efficacy among workers with WRSDs.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adult (≧ 18 years) employed full-time (minimum of 30 hours per week).
  • Experiencing work-related shoulder disorders (WRSDs), with minimal score of 14 points on the for the abbreviated version of the Disability of the Arm Shoulder and Hand questionnaire (QuickDASH), stemming from a diagnosis of rotator cuff-related shoulder pain (RCRSP), shoulder osteoarthritis (SOA) or rheumatoid arthritis (RA) involving the shoulder.
  • Symptoms persisting for more than 6 weeks.

Diagnosis-specific criteria:

  • RCRSP: diagnosis requires meeting three positive criteria, including the presence of a painful arc in abduction, a positive Neer sign, Hawkins-Kennedy test, or Jobe Test, pain with resisted humeral external rotation;
  • SOA: diagnosis based on clinical findings (e.g., activity-related pain, reduced range of motion particularly external rotation and function, worsening night/rest pain) and radiologic findings (e.g., osteophytes, joint space narrowing, subchondral sclerosis, cyst formations, and humeral head deformities);
  • RA involving the shoulder: confirmed diagnosis according to the American College of Rheumatology criteria.

Both SOA and RA diagnoses will be confirmed by a physician.

Exclusion criteria

  • clinical signs of a massive rotator cuff tear (e.g., pseudoparesis or pseudoparalysis, passive elevation intact but active limited to <90°, without neurologic deficit);
  • acute traumatic rotator cuff tears, fractures, adhesive capsulitis (characterized by night pain, pain with sudden or unexpected movements, global loss of active and passive range of motion), or shoulder instability (evidenced by a combination of orthopaedic tests such as apprehension and relocation tests, Jerk, Kim and posterior tests, along with and clinical signs like neuromuscular function impairment, history of instability, lesion mechanisms, worries that their shoulder could dislocate during activities);
  • distal neurovascular symptoms (e.g., thoracic outlet syndrome, venous thromboembolism);
  • previous shoulder surgery;
  • corticosteroid injection administered within the past 3 months;
  • symptomatic acromioclavicular joint pathology;
  • currently receiving conservative management for their shoulder pain (excluding medication for RA and OA),
  • absenteeism from work (unable to work at least 30 hours per week or on sick leave).

Treatment and study plan

Shoulder watch load (SWL) feedback

Device

During week 2 and 3 after randomization, the experimental group will undergo the intervention using the SWL, designed to monitor workers' physical work demands. During this time, the SWL will provide real-time feedback based on parameters set via Ergowatchapp. A workplace visit by a physiotherapist will be conducted to establish and adjust the feedback thresholds in week 2, after the education intervention. If necessary, a second remote meeting will take place in week 3 to explain how participants can modify the thresholds themselves. The initial feedback thresholds will be set based on the physical work demands measured during week 1 and will be adjusted after one week of feedback use. These thresholds will be collaboratively determined by a physiotherapist and the workers. Only the experimental group will receive feedback from the SWL during the study period.

Education

Other

Participants will receive an education intervention delivered by a physiotherapist. This intervention will take place preferentially at the participants' workplace at the end of the 2nd week post-randomization. The session will last 30 to 45 minutes, and involve personalized, patient-centered education on their condition. The physiotherapist will use open-ended questions to encourage participants to express their goals and address specific concerns related to their shoulder condition. Given the expected diversity in physical constraints (manual vs. non-manual workers) and individual challenges, the session will be tailored to each worker needs. At the end of the session, workers will receive a booklet summarizing key points, including: understanding shoulder anatomy, function and pain, managing shoulder pain, enhancing movement variability, adjusting work environment, and considering factors such as sleep, stress, coping mechanisms, and psychological factors on pain.

Primary outcomes

  1. Feasibility : quantitative component procedure

    Time frame: Baseline

    Assessing trial recruitment success (Recruitment rate) : Track the rate of screened participants who consent to participate in the trial, using a screening and recruitment log.

  2. Feasibility : quantitative component procedure

    Time frame: From enrollment to the end of recruitment

    Assessing trial recruitment success (Determining recruitment duration) : Evaluate the time required to recruit the target number of participants.

  3. Feasibility : quantitative component procedure

    Time frame: From enrollment to the end the trial at 12 weeks

    Assessing trial recruitment success (Retention rate) : Monitor the number of participants who complete the trial, and document reasons for attrition.

  4. Feasibility : quantitative component procedure

    Time frame: From enrollment to the end of the last completion questionnaire at 12 weeks

    Completion rate : Report the completion rate for each questionnaire at each time point.

  5. Feasibility : quantitative component procedure

    Time frame: From 2 weeks to 4 weeks of the intervention period

    Evaluating adherence to the intervention : Self-reported SWL devise usage: Participants in the experimental group will complete a self-reported questionnaire at the end of each week during the 2-week intervention period to assess their adherence to using the SWL.

  6. Feasibility : qualitative component procedure

    Time frame: From 4 weeks to 12 weeks

    Focus groups : All participants from the experimental group will be invited to participate to a focus group, to explore various aspects of feasibility such as the acceptability of the technology, the experience of wearing the SWL and receiving the feedback, and suggestion for potential improvement of the SWL.

Secondary outcomes

  1. Abbreviated version of the Disability of the Arm Shoulder and Hand questionnaire-Work Module (QuickDASH-Work Module)

    Time frame: Baseline, 3 weeks, 6 weeks, 12 weeks

    QuickDASH-Work Module includes 4 items, each scored from 1 to 5. This scale range from 0 to 100, with 0 indicating the best function and 100 indicating the worst possible function

  2. Abbreviated version of the Disability of the Arm Shoulder and Hand questionnaire (QuickDASH)

    Time frame: Baseline, 3 weeks, 6 weeks, 12 weeks

    The QuickDASH consists of 11 items, , each scored from 1 to 5. This scale range from 0 to 100, with 0 indicating the best function and 100 indicating the worst possible function.

  3. Work Limitations Questionnaire (WLQ-25).

    Time frame: Baseline, 3 weeks, 6 weeks, 12 weeks

    This 25-item questionnaire includes four subscales addressing four dimensions of job demands. The total score ranges from 0 to 100, with 0 indicating no limitation and 100 indicating complete limitation

  4. Pain severity subscale of the Brief Pain Inventory Short Form (BPI-SF)

    Time frame: Baseline, 3 weeks, 6 weeks, 12 weeks

    It includes 4 items measuring worst, least and average pain in the past 24 hours, as well as current pain, each scored on an 11-point numeric scale (0-10), where 0 indicates no pain and 10 represents the worst pain imaginable.

  5. Pain Self-Efficacy Questionnaire (PSEQ).

    Time frame: Baseline, 3 weeks, 6 weeks, 12 weeks

    This questionnaire includes 10 items, each scored on a 7-point Likert scale (0 = not at all confident and 6 = completely confident).

  6. Western Ontario Rotator Cuff Index (WORC)

    Time frame: Baseline, 3 weeks, 6 weeks, 12 weeks

    The WORC contains 21 items in total, each scored from 0 to 100, with 0 indicates best function and 100 indicating the worst possible function.

  7. Physical work demands

    Time frame: At 1 week and 4 weeks

    To evaluate physical work demands, workers in both groups will wear the SWL for three consecutive full working days during the 1st week (before the intervention for the experimental group). Participants will log their physical work demands daily using the Ergowatchapp via a Mycap entry. The following outcomes will be averaged for data analysis: 1) number of arm elevations (>60°) per day, 2) time spent with the arm elevated (>60°) per day.

Study contacts

Contact information is provided by the study sponsor or research team.

Jean-Sébastien Roy Jean-Sébastien Roy, PT, PhD

CONTACT

[email protected]

418-529-9141 ext. 46005

Philippe Meidinger PT, PhD student

CONTACT

[email protected]

Sponsors and collaborators

Lead sponsor

Laval University

Other

Collaborators

  • The Arthritis Society, Canada

Registry information

Official study title

Could a Feedback Device Help Manage Work-related Shoulder Disorders? - Protocol of a Mixed Methods Pilot Study

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
Nov 18, 2024
Registry last updated
May 8, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.